-
Signature
-
/s/ Bruce Blefeld, Attorney-in-Fact
-
Stock symbol
-
ZLAB
-
Transactions as of
-
Jun 23, 2023
-
Transactions value $
-
$280,020
-
Form type
-
4
-
Date filed
-
6/26/2023, 04:07 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ZLAB |
American Depositary Shares |
Options Exercise |
$462K |
+18.3K |
+82.03% |
$25.30 |
40.5K |
Jun 23, 2023 |
Direct |
F1, F2 |
transaction |
ZLAB |
American Depositary Shares |
Tax liability |
-$182K |
-7.18K |
-17.73% |
$25.30 |
33.3K |
Jun 23, 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ZLAB |
Restricted Share Units |
Options Exercise |
$0 |
-18.3K |
-25% |
$0.00 |
54.8K |
Jun 23, 2023 |
American Depositary Shares |
18.3K |
$0.00 |
Direct |
F1, F4, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases